Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 11/20 | 0.49 |
| ▸ | CDK4 | P11802 | 5/20 | 0.49 |
| ▸ | CCNE1 | P24864 | 5/20 | 0.49 |
| ▸ | CDK1 | P06493 | 1/20 | 0.43 |
| ▸ | AURKA | O14965 | 2/20 | 0.42 |
| ▸ | IGF1R | P08069 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | SYK | P43405 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7977441 | 0.89 | CDK2 (0.54) | CDK2CDK4CCNE1CDK1AURKA | |
| SCHEMBL699170 | 0.88 | CDK2 (0.50) | CDK2CDK4CCNE1CDK1AURKA | |
| SCHEMBL700586 | 0.83 | HDAC1 (0.61) | CDK2CDK4CCNE1IGF1RHDAC1 | |
| SCHEMBL7974320 | 0.83 | IGF1R (0.42) | CDK2CDK4CCNE1CDK1IGF1R | |
| SCHEMBL7976848 | 0.79 | CDK2 (0.53) | CDK2CDK4CCNE1CDK1AURKA | |
| SCHEMBL717540 | 0.79 | CDK2 (0.59) | CDK2CDK4CCNE1CDK1AURKA | |
| SCHEMBL7980219 | 0.79 | KDR (0.48) | CDK2CDK4CCNE1CDK1HDAC1 | |
| SCHEMBL7977194 | 0.78 | CDK2 (0.55) | CDK2CDK4CCNE1CDK1AURKA | |
| SCHEMBL10252086 | 0.77 | SYK (0.43) | CDK2CDK4CCNE1AURKASYK | |
| SCHEMBL7978525 | 0.76 | CDK2 (0.73) | CDK2CDK4CCNE1CDK1AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010009155-A2 | FUSED HETEROCYCLYC INHIBITOR COMPOUNDS | GILEAD COLORADO, INC. (US) | 2010-01-21 | — | — | WO | disclosed |